PTAB Won't Hear Dr. Reddy's Challenge To Revlimid Patents
The Patent Trial and Appeal Board on Monday rejected challenges from Dr. Reddy's Laboratories Inc. to three Celgene Corp. patents on the blockbuster cancer drug Revlimid, finding old Celgene press releases...To view the full article, register now.
Already a subscriber? Click here to view full article